The present invention relates to novel pharmaceutical compositions for topical administration of a compound Formula I and methods of treating or preventing cancer or pre-cancerous conditions or benign hyperproliferative disorders, by administering the composition to a subject in need thereof. In particular, the present invention provides a stable formulation of active a compound of Formula I useful for the treatment of disorders such as actinic keratosis.
